SPT6 recruits SND1 to co‐activate human telomerase reverse transcriptase to promote colon cancer progression

Human telomerase reverse transcriptase (hTERT) plays an extremely important role in cancer initiation and development, including colorectal cancer (CRC). However, the precise upstream regulatory mechanisms of hTERT in different cancer types remain poorly understood. Here, we uncovered the candidate transcriptional factor of hTERT in CRC and explored its role and the corresponding molecular mechanisms in regulating hTERT expression and CRC survival with an aim of developing mechanism‐based combinational targeting therapy. The possible binding proteins at the hTERT promoter were uncovered using pull‐down/mass spectrometry analysis. The regulation of SPT6 on hTERT expression and CRC survival was evaluated in human CRC cell lines and mouse models. Mechanistic studies focusing on the synergy between SPT6 and staphylococcal nuclease and Tudor domain containing 1 (SND1) in controlling hTERT expression and CRC progression were conducted also in the above two levels. The expression correlation and clinical significance of SPT6, SND1, and hTERT were investigated in tumor tissues from murine models and patients with CRC in situ. SPT6 was identified as a possible transcriptional factor to bind to the hTERT promoter. SPT6 knockdown decreased the activity of hTERT promoter, downregulated the protein expression level of hTERT, suppressed proliferation, invasion, and stem‐like properties, promoted apoptosis induction, and enhanced chemotherapeutic drug sensitivity in vitro. SPT6 silencing also led to the delay of tumor growth and metastasis in mice carrying xenografts of human‐derived colon cancer cells. Mechanistically, SND1 interacted with SPT6 to co‐control hTERT expression and CRC cell proliferation, stemness, and growth in vitro and in vivo. SPT6, SND1, and hTERT were highly expressed simultaneously in CRC tissues, both from the murine model and patients with CRC in situ, and pairwise expression among these three factors showed a significant positive correlation. In brief, our research demonstrated that SPT6 synergized with SND1 to promote CRC development by targeting hTERT and put forward that inhibiting the SPT6‐SND1‐hTERT axis may create a therapeutic vulnerability in CRC.

[1]  Hao Liu,et al.  Forkhead box K2 promotes human colorectal cancer metastasis by upregulating ZEB1 and EGFR , 2019, Theranostics.

[2]  Qiang Yang,et al.  Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits , 2019, Journal of Experimental & Clinical Cancer Research.

[3]  Wei Guo,et al.  BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits , 2018, Redox biology.

[4]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[5]  F. Winston,et al.  Spt6 is required for the fidelity of promoter selection , 2018, bioRxiv.

[6]  Alexander T. Adams,et al.  Spt6 Association with RNA Polymerase II Directs mRNA Turnover During Transcription. , 2018, Molecular cell.

[7]  D. Ekwueme,et al.  Colorectal Cancer Screening: Preferences, Past Behavior, and Future Intentions , 2018, The Patient - Patient-Centered Outcomes Research.

[8]  K. Ozato,et al.  SPT6 interacts with NSD2 and facilitates interferon‐induced transcription , 2018, FEBS letters.

[9]  A. Bardelli,et al.  Targeting the human epidermal growth factor receptor 2 (HER2) oncogene in colorectal cancer , 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

[10]  D. Weiner,et al.  Synergy of Immune Checkpoint Blockade with a Novel Synthetic Consensus DNA Vaccine Targeting TERT. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  S. Lattarulo,et al.  Study of the role of telomerase in colorectal cancer: preliminary report and literature review. , 2017, Il Giornale di chirurgia.

[12]  S. Uppugunduri,et al.  Uridine Ameliorates Dextran Sulfate Sodium (DSS)-Induced Colitis in Mice , 2017, Scientific Reports.

[13]  E. Totoń,et al.  Telomerase and drug resistance in cancer , 2017, Cellular and Molecular Life Sciences.

[14]  A. Jemal,et al.  Colorectal cancer statistics, 2017 , 2017, CA: a cancer journal for clinicians.

[15]  X. Liu,et al.  SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis , 2017, Oncogene.

[16]  J. Shay,et al.  hTERT promotes tumor angiogenesis by activating VEGF via interactions with the Sp1 transcription factor , 2016, Nucleic acids research.

[17]  Sarah J. Hainer,et al.  Regulation of chaperone binding and nucleosome dynamics by key residues within the globular domain of histone H3 , 2016, Epigenetics & Chromatin.

[18]  Jun S. Song,et al.  Understanding TERT Promoter Mutations: A Common Path to Immortality , 2016, Molecular Cancer Research.

[19]  Ji-Liang Li,et al.  hTERT mediates gastric cancer metastasis partially through the indirect targeting of ITGB1 by microRNA-29a , 2016, Scientific Reports.

[20]  B. Tang,et al.  Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression , 2015, Oncotarget.

[21]  Pui-Yan Kwok,et al.  Automated Assay of Telomere Length Measurement and Informatics for 100,000 Subjects in the Genetic Epidemiology Research on Adult Health and Aging (GERA) Cohort , 2015, Genetics.

[22]  S. Leow,et al.  Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity. , 2015, The Journal of clinical investigation.

[23]  M. Koopman,et al.  Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases , 2015, Clinical & Experimental Metastasis.

[24]  K. Sakimura,et al.  Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO. , 2015, Cancer discovery.

[25]  W. Xiong,et al.  Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells , 2016, Breast Cancer.

[26]  O. Silvennoinen,et al.  The transcriptional co-activator SND1 is a novel regulator of alternative splicing in prostate cancer cells , 2014, Oncogene.

[27]  K. Van Steen,et al.  Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti‐TNF alpha antibodies , 2014, Pharmacoepidemiology and drug safety.

[28]  R. Bertorelle,et al.  Telomeres, telomerase and colorectal cancer. , 2014, World journal of gastroenterology.

[29]  B. Chassaing,et al.  Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.

[30]  J. Yang,et al.  Telomerase reverse transcriptase promotes epithelial–mesenchymal transition and stem cell-like traits in cancer cells , 2013, Oncogene.

[31]  V. Sartorelli,et al.  The histone chaperone Spt6 coordinates histone H3K27 demethylation and myogenesis , 2013, The EMBO journal.

[32]  Gary L. Gallia,et al.  TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal , 2013, Proceedings of the National Academy of Sciences.

[33]  C. Mondello,et al.  Telomere-independent functions of telomerase in nuclei, cytoplasm, and mitochondria , 2012, Front. Oncol..

[34]  P. Fisher,et al.  Multifunction Protein Staphylococcal Nuclease Domain Containing 1 (SND1) Promotes Tumor Angiogenesis in Human Hepatocellular Carcinoma through Novel Pathway That Involves Nuclear Factor κB and miR-221* , 2012, The Journal of Biological Chemistry.

[35]  C. Harley,et al.  The telomerase inhibitor imetelstat depletes cancer stem cells in breast and pancreatic cancer cell lines. , 2010, Cancer research.

[36]  Johannes Söding,et al.  Uniform transitions of the general RNA polymerase II transcription complex , 2010, Nature Structural &Molecular Biology.

[37]  Young-Woo Sohn,et al.  Human telomerase catalytic subunit (hTERT) suppresses p53-mediated anti-apoptotic response via induction of basic fibroblast growth factor , 2010, Experimental & Molecular Medicine.

[38]  K. Kawakami,et al.  Deregulated GSK3 Sustains Gastrointestinal Cancer Cells Survival by Modulating Human Telomerase Reverse Transcriptase and Telomerase , 2009, Clinical Cancer Research.

[39]  A. Berk,et al.  Complexity in Transcription Control at the Activation Domain–Mediator Interface , 2009, Science Signaling.

[40]  K. Jones,et al.  The Iws1:Spt6:CTD complex controls cotranscriptional mRNA biosynthesis and HYPB/Setd2-mediated histone H3K36 methylation. , 2008, Genes & development.

[41]  O. Silvennoinen,et al.  p100 increases AT1R expression through interaction with AT1R 3′-UTR , 2008, Nucleic acids research.

[42]  Hanna S. Yuan,et al.  Structural and functional insights into human Tudor-SN, a key component linking RNA interference and editing , 2008, Nucleic acids research.

[43]  Shibo Jiang,et al.  Extracellular matrix protein betaig-h3/TGFBI promotes metastasis of colon cancer by enhancing cell extravasation. , 2008, Genes & development.

[44]  Markus F Neurath,et al.  An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression , 2007, Nature Protocols.

[45]  R. Evans,et al.  The Spt6 SH2 domain binds Ser2-P RNAPII to direct Iws1-dependent mRNA splicing and export. , 2007, Genes & development.

[46]  B. Gilchrest,et al.  Telomeric DNA induces apoptosis and senescence of human breast carcinoma cells , 2007, Breast Cancer Research.

[47]  D. Trisciuoglio,et al.  Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function , 2005, Cell Death and Differentiation.

[48]  Ruth I. Tennen,et al.  Conditional telomerase induction causes proliferation of hair follicle stem cells , 2005, Nature.

[49]  D. Jackson,et al.  The amazing complexity of transcription factories. , 2005, Briefings in functional genomics & proteomics.

[50]  T. Pawlik,et al.  Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  James M. Roberts,et al.  Telomerase modulates expression of growth-controlling genes and enhances cell proliferation , 2003, Nature Cell Biology.

[52]  R. Cawthon.  Telomere measurement by quantitative PCR. , 2002, Nucleic acids research.

[53]  C. Lamers,et al.  Malignancies in Inflammatory Bowel Disease: Fact or Fiction? , 2002, Scandinavian journal of gastroenterology. Supplement.

[54]  C. Greider,et al.  Telomerase activation: one step on the road to cancer? , 1999 .